[Associations of hemostasis factors genes with early development of ischemic heart disease and manifestation of myocardial infarction in young age]

Autor: En, Dankovtseva, Dmitry Zateyshchikov, Da, Chudakova, Os, Koroleva, An, Brovkin, Vv, Nosikov, Nv, Gaĭdukova, Va, Tishchenko, Ba, Sidorenko

Publikováno v: Europe PubMed Central

To study polymorphisms of genes of factors of the system of hemostasis in young patients with ischemic heart disease (IHD).Two groups of patients participated in the study: patients with first manifestation of IHD at the ageor = 50 years (men) oror =

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3f2d71d3bb5291d008de1b6a748d1662
https://pubmed.ncbi.nlm.nih.gov/16353042

[Association of polymorphic marker A1/A2 of gene ITGB3 with coronary artery disease and myocardial infarction]

Autor: Da, Chudakova, Lo, Minushkina, Dmitry Zateyshchikov, Vv, Nosikov

Publikováno v: Europe PubMed Central

The distributions of the alleles and genotypes of polymorphic marker A1/A2 of gene ITGB3 encoding the beta3 subunit of integrin alphaIIbbeta3 in groups of patients with coronary artery disease (CAD), including those who have had myocardial infarction

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::25091cf10df5837e617fcc6ce8768d4c
http://europepmc.org/abstract/med/15575508

Non-Tumor Cells within the Tumor Microenvironment-The "Eminence Grise" of the Glioblastoma Pathogenesis and Potential Targets for Therapy.

Autor: Bugakova AS; Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia., Chudakova DA; Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia., Myzina MS; Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia., Yanysheva EP; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia., Ozerskaya IV; Pulmonology Research Institute, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia., Soboleva AV; Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia.; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia., Baklaushev VP; Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia.; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.; Pulmonology Research Institute, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.; Department of Medical Nanobiotechnology of Medical and Biological Faculty, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, 117997 Moscow, Russia., Yusubalieva GM; Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia.; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.

Publikováno v: Cells [Cells] 2024 May 09; Vol. 13 (10). Date of Electronic Publication: 2024 May 09.

Improving Efficiency of Direct Pro-Neural Reprogramming: Much-Needed Aid for Neuroregeneration in Spinal Cord Injury.

Autor: Chudakova DA; Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia., Samoilova EM; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.; Federal Research and Clinical Center of Specialised Medical Care and Medical Technologies FMBA of Russia, 115682 Moscow, Russia., Chekhonin VP; Department of Medical Nanobiotechnology of Medical and Biological Faculty, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, 117997 Moscow, Russia., Baklaushev VP; Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia.; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.; Federal Research and Clinical Center of Specialised Medical Care and Medical Technologies FMBA of Russia, 115682 Moscow, Russia.; Department of Medical Nanobiotechnology of Medical and Biological Faculty, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, 117997 Moscow, Russia.

Publikováno v: Cells [Cells] 2023 Oct 20; Vol. 12 (20). Date of Electronic Publication: 2023 Oct 20.

The growth hormone receptor interacts with transcriptional regulator HMGN1 upon GH-induced nuclear translocation.

Autor: Jain L; The Liggins Institute, University of Auckland, 85 Park Rd, Private Bag 92019, Auckland, 1142, New Zealand., Vickers MH; The Liggins Institute, University of Auckland, 85 Park Rd, Private Bag 92019, Auckland, 1142, New Zealand., Jacob B; Faculty of Science, University of Auckland, Auckland, New Zealand., Middleditch MJ; Faculty of Science, University of Auckland, Auckland, New Zealand., Chudakova DA; School of Biological Sciences, University of Auckland, Auckland, New Zealand., Ganley ARD; School of Biological Sciences, University of Auckland, Auckland, New Zealand., O'Sullivan JM; The Liggins Institute, University of Auckland, 85 Park Rd, Private Bag 92019, Auckland, 1142, New Zealand. justin.osullivan@auckland.ac.nz., Perry JK; The Liggins Institute, University of Auckland, 85 Park Rd, Private Bag 92019, Auckland, 1142, New Zealand. j.perry@auckland.ac.nz.

Publikováno v: Journal of cell communication and signaling [J Cell Commun Signal] 2023 Sep; Vol. 17 (3), pp. 925-937. Date of Electronic Publication: 2023 Apr 12.